Bank of Nova Scotia’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Bank of Nova Scotia's ABMD Position: Q4 2022 in Review
Bank of Nova Scotia sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,795 shares — an estimated $932K sold.
Bank of Nova Scotia first reported a position in ABMD in Q2 2016 and held it in 17 quarters. The position peaked at $17.4M in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Bank of Nova Scotia reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Bank of Nova Scotia sold 3,795 Abiomed Inc shares in Q4 2022, an estimated $932K.
- Bank of Nova Scotia first reported a position in Abiomed Inc in Q2 2016 and held it in 17 quarters.
- Bank of Nova Scotia's Abiomed Inc position peaked at $17.4M in Q4 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Bank of Nova Scotia's 13F filing for Q4 2022, filed 9 Feb 2023.